Last Updated:
NameDesignationAppointment DateStatus
Manju Bist

Appointed as Director since August 2024

Director20-Aug-2024Current
Rajneesh Mehta

Appointed as Director since February 2026

Director10-Feb-2026Current
Suman

Appointed as Director since May 2026

Director13-May-2026Current
Ashok Saroha

Appointed as CEO since May 2023

CEO31-May-2023Current
Neha Singh

Appointed as Company Secretary since June 2026

Company Secretary03-Jun-2026Current
Sumeet Sood

Appointed as CFO since June 2022

CFO10-Jun-2022Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Unosource Pharma Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Unosource Pharma Limited's leadership journey.

Loading...
Contact Details
  • Address 305, Third Floor, C-Block, Plot No. 5 Mohan Place, Saraswati Vihar, Delhi, 110034, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Unosource Pharma Limited through their registered address at 305, Third Floor, C-Block, Plot No. 5 Mohan Place, Saraswati Vihar, Delhi, 110034, India, or via their website at unosourcepharma.com. Social media links are also provided where applicable.
The current directors of Unosource Pharma Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • Rajneesh Mehta
  • MANJU BIST
  • SUMAN
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available